SUBSCRIBE
SUBSCRIBE
News   FDA

GlaxoSmithKline Gets U.S. Lamictal XR FDA Approval

June 1, 2009 | 
1 min read
Reuters -- GlaxoSmithKline, the world's second-largest drugmaker, said on Monday that its Lamictal XR epilepsy drug had been approved in the United States.
FDA Approvals
GlaxoSmithKline Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Collage with halftone hands putting puzzle together. Teamwork concept vector pop art retro style illustration. Partnership and relationship design element for infographic, poster, website
Rare diseases
FDA Signs Off on Neurogene’s ‘Best-Case Scenario’ Pivotal Study Design for Rett Syndrome
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
June 30, 2025
 · 
6 min read
 · 
Natalia Mesa
Vaccines
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety
June 27, 2025
 · 
2 min read
 · 
Jef Akst
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Neurodegenerative disease
Edgewise Takes a Hit as FDA Blocks Accelerated Path for Becker Muscular Dystrophy Drug
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac